Discover Innovations in Gene Therapy Manufacturing!
We recently released several Reports on Cell and Gene Therapy (CGT) as it is considered a significant development in disease management with notable implications for
September 5, 2025
We recently released several Reports on Cell and Gene Therapy (CGT) as it is considered a significant development in disease management with notable implications for
The FDA recently approved a new oral therapy, Ibtrozi (taletrectinib) from Nuvation Bio Inc., indicated for the treatment of adult patients with locally advanced or
Announcements for newly approved specialty drugs often state that the product will be available through specialty pharmacy in limited distribution. However, the early press releases
Today’s article posed a seemingly straightforward question: Is there a marketplace for mail order? Our initial response was an emphatic “YES.” However, after further reading,
States are increasingly targeting PBMs, as media scrutiny of PBM practices intensifies and PBMs respond with legal action. Arkansas, for example, has sought relief from
It is common to focus on the exciting approvals of cell and gene therapies. However, there has also been significant progress in the small molecule
The FDA recently approved yet another biosimilar to Stelara. Starjemza (ustekinumab-hmny) is from Bio-Thera Solutions and Hikma Pharmaceuticals. The lineup of the previously approved Stelara
The FDA recently approved a new therapy, Avmapki Fakzynja Co-Pack (avutometinib capsules; defactinib tablets) from Verastem Oncology, indicated for the treatment of adult patients with
As our understanding of cell and gene therapy deepens, the demand for specialized knowledge and expertise grows. This document explores the manufacturing and even shipment
The FDA recently approved a new therapy, Emrelis (telisotuzumab vedotin-tllv) from AbbVie, indicated for the treatment of adult patients with locally advanced or metastatic non-squamous